iSono Health, Inc.

iSono Health, Inc. is a US-based medical technology company focused on developing advanced breast imaging solutions to enhance early cancer detection and diagnosis, primarily through their innovative ATUSA system. Founded in 2015 and headquartered in South San Francisco, US, iSono Health, Inc. specializes in automated breast imaging technology.

The company has undergone strategic operational adjustments to enhance its product offerings but does not have any known subsidiaries or parent companies. The founder's history is not specified, and the company has participated in 1 funding deal, with the most recent deal occurring on October 14, 2025. iSono Health specializes in innovative breast imaging technology, with its core product being the ATUSA system. The ATUSA scanner enables fully automated, hands-free ultrasound imaging of the entire breast volume, significantly enhancing the speed and convenience of breast cancer screening.

Operating in just two minutes per breast, the device captures comprehensive 3D images and localizes lesions without requiring a trained ultrasound operator, thus addressing the need for accessible and efficient breast imaging solutions in healthcare settings. Targeted primarily at physicians' offices and women's health clinics, the ATUSA system is designed for use by physicians, nurses, and medical assistants, facilitating a user-friendly experience for both healthcare professionals and patients. The company's technology is currently under investigational use and is not yet commercially available; however, it is poised to cater to markets in North America and Europe as it moves towards broader adoption. iSono Health's revenue generation framework is primarily based on transactions involving the ATUSA system, which includes a combination of hardware and software components.

The company engages healthcare facilities and professionals through a pilot program, allowing them to register for demonstrations and express interest in the technology. This approach fosters direct partnerships with healthcare providers who utilize the ATUSA system in their practices. The financial structure centers around device sales, software licensing for the accompanying applications, and potential service agreements related to support and training. The ATUSA system's unique capabilities position iSono Health to establish a competitive foothold in the breast imaging market, targeting revenue growth through the cultivation of long-term relationships with medical practices focused on enhancing patient care.

In October 2025, iSono Health, Inc. raised an undisclosed amount of venture funding led by new investor JSK Investments. The company will utilize this funding to improve its breast scanning system, continue clinical testing, and work with more healthcare providers to reach more patients. Upcoming plans include expanding the reach of their ATUSA system into new markets across North America and Europe as the technology progresses toward commercial availability.